Latest Breaking News On - Chris basta - Page 5 : vimarsana.com

Immutep Successfully Completes Institutional Placement and Institutional Component of its Entitlement Offer

Immutep Successfully Completes Institutional Placement and Institutional Component of its Entitlement Offer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New south walesUnited statesNew zealandChris bastaRussell howardImmutep newsharesCorporate communicationsInstitutional entitlement offerEntitlement offerInstitutional offerNew shareInstitutional entitlementOffer immutepLymphocyte activationInvestor relationsNew shares

Immutep Selects Charles River Laboratories for IMP761 s GLP Toxicology Study

Media Release Appointment of Charles River Laboratories to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP761Forms a key step prior to. | May 29, 2023

New south walesChris bastaImmutep limitedGlobenewswire incCorporate communicationsCharles river laboratoriesCharles riverChief scientific officerLymphocyte activationInvestor relationsImmutep limited stock exchangePress releaseRior imm au000000imm6

Immutep (IMMP) Announces Publication of Abstracts

Immutep (IMMP) Announces Publication of Abstracts
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity hospitalChris bastaBernard dogerNuhadk ibrahimUniversity of texas md anderson cancer centerDivision of cancer medicineDepartment of breast medical oncologyCorporate communicationsImmutep limitedAmerican society of clinical oncologyDrug administrationWall streetClinical oncologyAnnual meetingNeck cancerdate

Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting

Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesUniversity hospitalBernard dogerNuhadk ibrahimChris bastaCorporate communicationsDrug administrationDivision of cancer medicineImmutep limitedDepartment of breast medical oncologyUniversity of texas md anderson cancer centerAmerican society of clinical oncologyWall streetComplete responsePositive score

Immutep s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer

Media Release Immuno-oncology combination of eftilagimod alpha and the leading anti-PD-1 therapy generates meaningful long-term survival in non-small cell lung cancer patients in Phase II TACTI-002. | May 17, 2023

New south walesCity ofUnited kingdomUnited statesUniversity collegeChris bastaMarc voigtMartin forsterAmerican cancer societyDrug administrationImmutep limitedData monitoring committeeUniversity college london hospitalCorporate communicationsMerck co incSociety for immunotherapy of cancer